These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Histone Methylases and Demethylases Regulating Antagonistic Methyl Marks: Changes Occurring in Cancer. Taylor-Papadimitriou J; Burchell JM Cells; 2022 Mar; 11(7):. PubMed ID: 35406676 [TBL] [Abstract][Full Text] [Related]
4. Remodeling of heterochromatin structure slows neuropathological progression and prolongs survival in an animal model of Huntington's disease. Lee J; Hwang YJ; Kim Y; Lee MY; Hyeon SJ; Lee S; Kim DH; Jang SJ; Im H; Min SJ; Choo H; Pae AN; Kim DJ; Cho KS; Kowall NW; Ryu H Acta Neuropathol; 2017 Nov; 134(5):729-748. PubMed ID: 28593442 [TBL] [Abstract][Full Text] [Related]
5. The H3K27 demethylase UTX-1 regulates C. elegans lifespan in a germline-independent, insulin-dependent manner. Maures TJ; Greer EL; Hauswirth AG; Brunet A Aging Cell; 2011 Dec; 10(6):980-90. PubMed ID: 21834846 [TBL] [Abstract][Full Text] [Related]
6. Histone demethylase UTX counteracts glucocorticoid deregulation of osteogenesis by modulating histone-dependent and -independent pathways. Wang FS; Lian WS; Lee MS; Weng WT; Huang YH; Chen YS; Sun YC; Wu SL; Chuang PC; Ko JY J Mol Med (Berl); 2017 May; 95(5):499-512. PubMed ID: 28130569 [TBL] [Abstract][Full Text] [Related]
7. Age-associated chromatin relaxation is enhanced in Huntington's disease mice. Park M; Min B; Jeon K; Cho S; Park JS; Kim J; Jeon J; Song J; Kim S; Jeong S; Seo H; Kang YK Aging (Albany NY); 2017 Mar; 9(3):803-822. PubMed ID: 28288000 [TBL] [Abstract][Full Text] [Related]
8. Epigenetics of Huntington's Disease. Bassi S; Tripathi T; Monziani A; Di Leva F; Biagioli M Adv Exp Med Biol; 2017; 978():277-299. PubMed ID: 28523552 [TBL] [Abstract][Full Text] [Related]
9. Targeting H3K4 trimethylation in Huntington disease. Vashishtha M; Ng CW; Yildirim F; Gipson TA; Kratter IH; Bodai L; Song W; Lau A; Labadorf A; Vogel-Ciernia A; Troncosco J; Ross CA; Bates GP; Krainc D; Sadri-Vakili G; Finkbeiner S; Marsh JL; Housman DE; Fraenkel E; Thompson LM Proc Natl Acad Sci U S A; 2013 Aug; 110(32):E3027-36. PubMed ID: 23872847 [TBL] [Abstract][Full Text] [Related]
17. The Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington's Disease. Dong X; Tsuji J; Labadorf A; Roussos P; Chen JF; Myers RH; Akbarian S; Weng Z PLoS One; 2015; 10(12):e0144398. PubMed ID: 26636336 [TBL] [Abstract][Full Text] [Related]
18. A histone H3 lysine 27 demethylase regulates animal posterior development. Lan F; Bayliss PE; Rinn JL; Whetstine JR; Wang JK; Chen S; Iwase S; Alpatov R; Issaeva I; Canaani E; Roberts TM; Chang HY; Shi Y Nature; 2007 Oct; 449(7163):689-94. PubMed ID: 17851529 [TBL] [Abstract][Full Text] [Related]
19. Specific promoter deacetylation of histone H3 is conserved across mouse models of Huntington's disease in the absence of bulk changes. Guiretti D; Sempere A; Lopez-Atalaya JP; Ferrer-Montiel A; Barco A; Valor LM Neurobiol Dis; 2016 May; 89():190-201. PubMed ID: 26851501 [TBL] [Abstract][Full Text] [Related]
20. Coordinated demethylation of H3K9 and H3K27 is required for rapid inflammatory responses of endothelial cells. Higashijima Y; Matsui Y; Shimamura T; Nakaki R; Nagai N; Tsutsumi S; Abe Y; Link VM; Osaka M; Yoshida M; Watanabe R; Tanaka T; Taguchi A; Miura M; Ruan X; Li G; Inoue T; Nangaku M; Kimura H; Furukawa T; Aburatani H; Wada Y; Ruan Y; Glass CK; Kanki Y EMBO J; 2020 Apr; 39(7):e103949. PubMed ID: 32125007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]